On Tuesday, March 20, 2012, the Lester Center for Entrepreneurship will proudly bestow its 2012 Lifetime Achievement Award in Entrepreneurship to Moshe Alafi, Founder and Principal of Alafi Capital Company LLC. The Lester Center for Entrepreneurship at the Haas School of Business, University of California Berkeley is proud to honor Moshe Alafi with its Lifetime […]Read More
Moshe Alafi will be presented with the Lifetime Achievement in Entrepreneurship Award for 2012 by the Lester Center for Entrepreneurship at the Haas School of Business, University of California Berkeley on Tuesday, March 20th. Moshe has been a mentor to me and Claremont Creek Ventures is proud to be a sponsor of this event. You may register […]Read More
March 7, 2012 source: Angel Capital Association (ACA) AssureRx Health, Inc. Receives 2012 ACA Luis Villalobos Award for Innovation Angel Capital Association Recognizes Company For Industry-leading Personalized Medicine Solution Hats off to one of my portfolio companies, AssureRx today received the the 2012 Luis Villalobos Award from the Angel Capital Association (ACA), the trade association of […]Read More
On February 22, I had the pleasure of speaking with Douglas Crawford, the associate director of QB3 the California Institute for Quantitative Biosciences in Berkeley –. It was quite exciting to be the first guest on their new podcast, QB3 Bio Entrepreneurship. During our lively hour discussion, I had the opportunity to share my thoughts on […]Read More
Successful venture capital investing in molecular diagnostics requires proper commercialization of innovation. But how does this innovation get brought to market? The panel will explore the challenges of commercialization in a still-difficult business environment. These challenges include the cost-efficient development of technology that is truly disruptive yet cost-competitive. Panelists will discuss how to best determine […]Read More
I will be moderating a panel, Venture Capitalists’ Best Practices on Commercializing Innovation at the Molecular Diagnostics World Congress on September 29, 2011 at the South San Francisco Conference Center. Here’s the panel topic summary, hope to see you there. Successful venture capital investing in molecular diagnostics requires proper commercialization of innovation. But how does this innovation get […]Read More
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.